Empagliflozin shows efficacy when added to metformin and sulfonylurea

08/27/2013 | MedPage Today (free registration)

Type 2 diabetes patients who took daily doses of empagliflozin as an add-on to metformin/sulfonylurea treatment attained greater reductions in A1C at six months than those in the placebo group, according to a study in Diabetes Care. Greater weight loss and improved systolic blood pressure were also seen in the empagliflozin arm compared with the control group, researchers noted.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX